Sonam Kiwalkar, MD, from Oregon Health and Science University, discusses the importance of exercise for the management of ankylosing spondylitis, how rheumatologists can help enforce a successful regimen, and more.

Sonam Kiwalkar, MD, from Oregon Health and Science University, discusses the importance of exercise for the management of ankylosing spondylitis, how rheumatologists can help enforce a successful regimen, and more.

Sonam Kiwalkar, MD, from Oregon Health and Science University, discusses the importance of exercise for the management of ankylosing spondylitis, how rheumatologists can help enforce a successful regimen, and more.

Sonam Kiwalkar, MD, from Oregon Health and Science University, discusses the importance of exercise for the management of ankylosing spondylitis, how rheumatologists can help enforce a successful regimen, and more.

Dr James Matera from CentraState Medical Center in Freehold, NJ, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal transplant candidates have undergone their procedure.

Dr James Matera from CentraState Medical Center in Freehold, NJ, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal transplant candidates have undergone their procedure.

Dr James Matera from CentraState Medical Center in Freehold, NJ, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal transplant candidates have undergone their procedure.

Dr James Matera from CentraState Medical Center in Freehold, NJ, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal transplant candidates have undergone their procedure.

Dr James Matera from CentraState Medical Center in Freehold, NJ, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal transplant candidates have undergone their procedure.

Dr James Matera from CentraState Medical Center in Freehold, NJ, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal transplant candidates have undergone their procedure.